Collegium Pharmaceutical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Revenue	566.77	463.93	276.87	310.02	296.7	280.41	28.48	1.71	0	0	Upgrade
Revenue Growth (YoY)	22.17%	67.56%	-10.69%	4.49%	5.81%	884.73%	1564.29%	-	-	-	Upgrade
Cost of Revenue	240.6	254.45	126.25	130.18	193.66	165.68	2.6	0.21	0	0	Upgrade
Gross Profit	326.17	209.49	150.62	179.84	103.04	114.74	25.88	1.5	0	0	Upgrade
Selling, General & Admin	159.21	172.19	118.96	113.83	116.45	126.76	92.76	80.63	18.93	2.71	Upgrade
Research & Development	0	3.98	9.45	9.77	10.34	8.66	8.57	14.95	7.98	14.96	Upgrade
Other Operating Expenses	0	0	4.58	0	0	0	0	0	0	0	Upgrade
Operating Expenses	159.21	176.17	132.99	123.6	126.79	135.42	101.33	95.58	26.91	17.67	Upgrade
Operating Income	166.96	33.32	17.63	56.23	-23.75	-20.69	-75.45	-94.08	-26.91	-17.67	Upgrade
Interest Expense / Income	83.34	63.21	21.01	28.88	0.91	20.13	0	0.09	0.44	0.25	Upgrade
Other Expense / Income	7.89	-1.05	-0.01	-0.23	-1.94	-1.69	-0.58	-	-0.09	-	Upgrade
Pretax Income	75.73	-28.85	-3.37	27.58	-22.72	-39.13	-74.87	-94.18	-27.26	-17.92	Upgrade
Income Tax	27.58	-3.85	-74.89	0.83	0	0	0	0	0	0	Upgrade
Net Income	48.16	-25	71.52	26.75	-22.72	-39.13	-74.87	-94.18	-27.26	-17.92	Upgrade
Net Income Growth	-	-	167.33%	-	-	-	-	-	-	-	Upgrade
Shares Outstanding (Basic)	34	34	35	34	33	33	30	24	14	1	Upgrade
Shares Outstanding (Diluted)	42	34	41	35	33	33	30	24	14	1	Upgrade
Shares Change	23.53%	-17.58%	16.77%	5.07%	1.52%	8.88%	24.74%	79.16%	1349.93%	-44.96%	Upgrade
EPS (Basic)	1.43	-0.74	2.05	0.78	-0.68	-1.19	-2.47	-3.88	-1.48	-22.72	Upgrade
EPS (Diluted)	1.29	-0.74	1.86	0.76	-0.68	-1.19	-2.47	-3.88	-1.48	-22.72	Upgrade
EPS Growth	-	-	144.74%	-	-	-	-	-	-	-	Upgrade
Free Cash Flow	274.29	122.61	101.61	-279.83	21.35	145.04	-68.01	-75.53	-21.93	-17.96	Upgrade
Free Cash Flow Per Share	8.13	3.62	2.91	-8.13	0.64	4.40	-2.25	-3.11	-1.62	-19.22	Upgrade
Gross Margin	57.55%	45.15%	54.40%	58.01%	34.73%	40.92%	90.89%	87.55%	-	-	Upgrade
Operating Margin	29.46%	7.18%	6.37%	18.14%	-8.00%	-7.38%	-264.95%	-5498.66%	-	-	Upgrade
Profit Margin	8.50%	-5.39%	25.83%	8.63%	-7.66%	-13.95%	-262.91%	-5504.15%	-	-	Upgrade
Free Cash Flow Margin	48.40%	26.43%	36.70%	-90.26%	7.19%	51.72%	-238.83%	-4414.38%	-	-	Upgrade
Effective Tax Rate	36.41%	-	-	3.01%	-	-	-	-	-	-	Upgrade
EBITDA	308.33	173.31	86.56	118.07	-20.77	-17.92	-74.27	-93.43	-26.65	-17.48	Upgrade
EBITDA Margin	54.40%	37.36%	31.26%	38.09%	-7.00%	-6.39%	-260.82%	-5460.37%	-	-	Upgrade
Depreciation & Amortization	149.26	138.94	68.92	61.61	1.04	1.07	0.59	0.66	0.17	0.19	Upgrade
EBIT	159.07	34.37	17.64	56.46	-21.81	-19	-74.87	-94.08	-26.82	-17.67	Upgrade
EBIT Margin	28.07%	7.41%	6.37%	18.21%	-7.35%	-6.78%	-262.91%	-5498.66%	-	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).